DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED STUDY OF EFFICIENCY AND SAFETY OF COMPLEX ACETYL-L-CARNITINE, L-CARNITINE FUMARATE AND ALPHA-LIPOIC ACID (SPERMACTIN® FORTE) FOR TREATMENT OF MALE INFERTILITY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Oxidative stress of sperm is a common pathologic condition, which can be detected in 30-80% infertile men. It is established that dietary consumption of antioxidants and microelements contributes to an increase of conception probability in subfertile couples, and also reduces the risk of reproductive losses. Drug complexes influencing various factors of spermatogenesis disturbance (oligo-, astheno-, teratozoospermia), oxidative stress and the level of sperm DNA fragmentation are of greatest and reasonable interest. Aim. To study the effects of complex acetyl-l-carnitine, l-carnitine fumarate and alpha-lipoic acid (SpermActin® Forte) on oxidative stress, ejaculate quality and sperm DNA fragmentation in men with infertility. Materials and methods. A total of 80 infertile men aged 25-40 years with increased level of sperm DNA fragmentation and oxidative stress were included in open-label, prospective, randomized study. In Group A (n=20) patients received a placebo for 180 days, and in Group B patients were prescribed to SpermActin® Forte, 1 sachet of 10 g once a day. The criteria for the efficiency of therapy included sperm analysis, the level of sperm DNA fragmentation, the level of sperm oxidative stress, as well as information about achievement of pregnancy, obtained by interviewing all participants. Results: In patients taking antioxidant complex SpermActin® Forte there were significant positive changes in the main parameters of sperm analysis, including sperm mobility and morphology starting from the third month of therapy. The level of free oxygen radicals (as indicator of oxidative stress) in Group B also significantly decreased (by 86%). A more profound decrease in DNA fragmentation was seen in Group B compared to Group A (21.5% vs. 3.6%). Pregnancy was achieved in 1 and 13 cases in Group A and B, respectively. Conclusion. The use of the SpermActin® Forte antioxidant complex allowed to improve sperm analysis in most patients, and these changes were significant starting from the third month of therapy. Stimulation of spermatogenesis using the antioxidant complex SpermActin® Forte is an effective and safe method of treating male infertility.

Full Text

Restricted Access

About the authors

S. I Gamidov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia; GBOU VPO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: safargamidov@yandex.ru
MD, professor at the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, Head of the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia Moscow, Russia

R. I Ovchinnikov

National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia

Email: r_ovchinnikov@oparina4.ru
Ph.D., Head of the Department of Andrology and Urology Moscow, Russia

A. Yu Popova

IPO GBOU VPO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: a_popova@oparina4.ru
Ph.D., senior researcher at the Department of Andrology and Urology of National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia, associate professor at the Department of Obstetrics, Gynecology, Perinatology and Reproductology of IPO GBOU VPO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia Moscow, Russia

References

  1. Wong W.Y., Thomas C.M., Merkus J.M., Zielhuis G.A., Steegers-Theunissen R.P. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril. 2000;73(3):435-442.
  2. Ko E., Siddiqi K., Brannigan R., Sabanegh E. Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. J. Urol. 2012;187:973-978.
  3. Hamada A., Esteves S.C., Nizza M., Agarwal A. Unexplained male infertility: diagnosis and management. Int Braz J Urol. 2012;38:576-594. doi: 10.1590/S1677-55382012000500002.
  4. Lenzi A., Lombardo F., Sgro P. et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 2003;79(2):292-300.
  5. Lenzi A., Sgro P., Salacone P., Paoli D., Gilio B., Lombardo F., et al. A placebo-controlled double-blind randomized trial of the use of combined 1-carnitine and 1-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steri1 2004; 81:1578-1584.
  6. Fernndez-Gonzalez R., Moreira P.N., Prez-Crespo M. et al. Long-term effects of mouse intra-cytoplasmic sperm injection with DNA-fragmented sperm on health and behavior of adult offspring. Biol Reprod. 2008; 78(4):761-772.
  7. Simon L., Liu L., Murphy K. et al. Comparative analysis of three sperm DNA damage assays and sperm nuclear protein content in couples undergoing assisted reproduction treatment. Hum Re-prod. 2014;29(5): 904-917.
  8. Zini A., Albert O., Robaire B. Assessing sperm chromatin and DNA damage: clinical importance and development of standards. Andrology. 2014;2(3):322-325.
  9. Saalu L.C. The incriminating role of reactive oxygen species in idiopathic male infertility: an evidence based evaluation. Pak J Biol Sci. 2010;13:413-422.
  10. Hampl R., Drábkovâ P., Kand’ár R., Stěpán J. Impact of oxidative stress on male infertility. Ceska Gynekol. 2012;77:241-245.
  11. El-Bahrawy K., El-Hassanein E.S., Kamel Y.M. Comparison of gentamycin and ciprofloxacin in dromedary camels’ semen extender. World J Agric Sci. 2010;6:419-424.
  12. Jarow J.P. Semen quality of male smokers and nonsmokers in infertile couples. J Urol. 2003;170:675-676.
  13. Chen S.J., Allam J.P., Duan Y.G., Haidl G. Influence of reactive oxygen species on human sperm functions and fertilizing capacity including therapeutical approaches. Arch Gynecol Obstet. 2013;288:191-199.
  14. Lanzafame FM, La Vignera S, Vicari E, Calogero AE. Oxidative stress and medical antioxidant treatment in male infertility. Reprod Biomed Online. 2009;19:638-659.
  15. Bansal A.K., Bilaspuri G.S. Impacts of oxidative stress and antioxidants on semen functions. Vet Med Int. 2010;2010:686137.
  16. Cochrane Database Syst Rev. 2011 Jan 19;1:CD007411 Antioxidants for male subfertility. Showell et al.
  17. Showell M.G. et al. Antioxidants for male subfertility.Cochrane Database of Syst Rev 2014, Issue 12. Art. No.: CD007411. doi: 10.1002/14651858. CD007411.pub3

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies